Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;19(11):755.
doi: 10.1038/d41573-020-00165-2.

Selectively triggering mitotic failure

Sarah Crunkhorn
Comment

Selectively triggering mitotic failure

Sarah Crunkhorn. Nat Rev Drug Discov. 2020 Nov.
No abstract available

PubMed Disclaimer

Comment on

  • TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.
    Meitinger F, Ohta M, Lee KY, Watanabe S, Davis RL, Anzola JV, Kabeche R, Jenkins DA, Shiau AK, Desai A, Oegema K. Meitinger F, et al. Nature. 2020 Sep;585(7825):440-446. doi: 10.1038/s41586-020-2710-1. Epub 2020 Sep 9. Nature. 2020. PMID: 32908304 Free PMC article.
  • Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.
    Yeow ZY, Lambrus BG, Marlow R, Zhan KH, Durin MA, Evans LT, Scott PM, Phan T, Park E, Ruiz LA, Moralli D, Knight EG, Badder LM, Novo D, Haider S, Green CM, Tutt ANJ, Lord CJ, Chapman JR, Holland AJ. Yeow ZY, et al. Nature. 2020 Sep;585(7825):447-452. doi: 10.1038/s41586-020-2690-1. Epub 2020 Sep 9. Nature. 2020. PMID: 32908313 Free PMC article.

References

    1. Yeow, Z. et al.Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. Nature https://doi.org/10.1038/s41586-020-2690-1 (2020)
    1. Meitinger, F. et al. TRIM37 controls cancer-specific vulnerability to PLK4 inhibition. Nature https://doi.org/10.1038/s41586-020-2710-1 (2020)

Substances

LinkOut - more resources